{"abstract": "Stiefel, now a GlaxoSmithKline subsidiary, is accused of undervaluing its private stock in employee buybacks while secretly negotiating to be bought.", "web_url": "https://dealbook.nytimes.com/2011/12/12/s-e-c-accuses-stiefel-scion-of-cheating-former-employees/", "snippet": "Stiefel, now a GlaxoSmithKline subsidiary, is accused of undervaluing its private stock in employee buybacks while secretly negotiating to be bought.", "lead_paragraph": "7:40 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "S.E.C. Accuses Stiefel Labs and Its Ex-Chief of Fraud", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "subject", "value": "Securities and Commodities Violations", "rank": 3, "major": "N"}, {"name": "subject", "value": "Suits and Litigation", "rank": 4, "major": "N"}, {"name": "organizations", "value": "GlaxoSmithKline PLC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Securities and Exchange Commission", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Stiefel Laboratories", "rank": 7, "major": "N"}], "pub_date": "2011-12-12T21:04:49+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Peter Lattman", "person": [{"firstname": "Peter", "middlename": null, "lastname": "Lattman", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/e578ad8f-b713-5563-a784-1dbe3b473952", "word_count": 697, "uri": "nyt://article/e578ad8f-b713-5563-a784-1dbe3b473952"}